No Data
No Data
Rocket Pharmaceuticals Down Over 14%, on Track for Lowest Close Since September 2017 -- Data Talk
How Peter Marks' FDA Departure Is Impacting Pharma, Biotech Stocks
Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now?
Cantor Fitzgerald Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $50
BMO Capital Initiates Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Announces Target Price $50
BMO Capital Initiates Coverage On Rocket Pharmaceuticals With Outperform Rating, Announces Price Target of $50